Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
31.1%
% of CANC's 45 holdings also in IDNA
29.8%
% of IDNA's 51 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus IDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IDNA |
Overlap | |
|---|---|---|---|---|
 |
MERCK & CO. INC. | 5.6% | 4.7% | 4.7% |
|
REGENERON PHARMACEUTICALS | 5.6% | 4.3% | 4.3% |
|
REVOLUTION MEDICINES, INC. | 3.1% | 5.6% | 3.1% |
|
GILEAD SCIENCES INC | 2.9% | 3.4% | 2.9% |
|
EXELIXIS INC | 2.4% | 4.0% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to IDNA
 |
DAIICHI SANKYO CO LTD | 4.0% |
 |
ASTRAZENECA PLC | 3.8% |
 |
NOVARTIS AG | 3.7% |
|
ILLUMINA INC | 3.5% |
|
EXACT SCIENCES CORP | 3.1% |
 |
ARGENX SE ADR | 2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | 2.7% |
|
CELLDEX THERAPEUTICS INC | 2.6% |
|
BRISTOL-MYERS SQUIBB CO | 2.5% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 2.1% |
CANC Underweight Relative to IDNA
|
SAREPTA THERAPEUTICS INC | -5.3% |
 |
SANOFI-AVENTIS | -3.9% |
|
TAKEDA PHARMACEUTICAL CO LTD | -3.6% |
 |
GENMAB A/S | -3.6% |
|
ROCHE HOLDING LTD | -3.5% |
 |
BIONTECH SE SPONSORED ADR | -3.4% |
 |
BEIGENE, LTD. | -3.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -3.0% |
|
MODERNA, INC. | -3.0% |
|
REVOLUTION MEDICINES, INC. | -2.4% |